|
|
CURRENT PRACTICE
|
|
|
International Medical Research, LLC, Principal Investigator/Owner
|
2004 – Present
|
|
Arthritis, Autoimmune, and Allergy
|
|
1430 Mason Avenue Daytona Beach, Fl. 32117
|
|
|
|
CLINICAL RESEARCH TRAINING & POSITIONS
|
|
|
Principal Investigator/Owner of International Medical Research – Daytona Beach, Fl
|
2004 – Present
|
|
ACRP National Conference, Investigator Track - Orlando, FL
|
2005
|
|
ACRP National Conference, Investigator Track – San Diego, CA
|
2004
|
|
ACRP Certified Clinical Research Investigator (CCTI)
|
2003
|
|
Clinical Research Training for Physicians – Orlando, FL
|
2003
|
Principal Investigator/Owner of Granada Clinical Research – Ormond, FL |
2002 – 2004 |
| Principal Investigator for Coastal Research – Daytona Beach, FL |
1996 – 2002 |
|
|
INTERNSHIP, RESIDENCY, FELLOWSHIPS & EDUCATION
|
|
|
The University of Michigan Medical School, Ann Arbor
Michigan Lecturer in Internal Medicine
|
1992 – 1993
|
|
Clinical Fellowships in both Rheumatology and Geriatric Medicine
|
1991 – 1993
|
|
|
The Johns Hopkins University Medical School, Baltimore, Maryland
Clinical Fellowship in Allergy and Clinical Immunology
|
1989 – 1991
|
|
Research Fellowship in Allergy and Clinical Immunology
|
1985 – 1986
|
|
Master of Health in Science –Immunology
|
1983 – 1985
|
|
|
Wayne State University, Detroit Medical Center, Detroit, Michigan
Internship and Residency in Internal Medicine
|
1986 – 1989
|
|
|
Lan-Yen Military Hospital, Taiwan
R. O. T. C. Medical Officer
|
1981 – 1983
|
|
|
China Medical College, Taichung, Taiwan
Medical Doctor
|
1974 – 1981
|
|
|
BOARD CERTIFICATIONS
|
|
| Certified Physician Investigator (CPI) |
2007-2009 |
|
Rheumatology
|
1994
|
|
Allergy & Immunology
|
1991
|
|
Internal Medicine
|
1989
|
|
|
PROFESSIONAL MEMBERSHIPS
|
|
|
Association of Clinical Research Professionals
|
|
International Rheumatology Network
|
|
American Academy of Allergy and Immunology
|
|
American College of Physicians
|
|
Florida Medical Association
|
|
Volusia County Medical Society
|
|
|
LICENSURE
|
|
|
State of Florida License #ME 0064560
|
|
ACRP certification #03S031
|
|
Tax ID# 59-1641-576
|
|
|
|
|
CLINICAL RESEARCH EXPERIENCE
|
|
|
Pozen
|
|
Protocol MT100-301, Acute migraine
|
06/99 – 12/99
|
|
Protocol MT100-302, Acute migraine
|
08/99 – 05/00
|
|
Protocol MT100-306, Acute migraine
|
04/00 – 08/00
|
|
Protocol MT300-201, Acute migraine
|
10/98 – 01/99
|
|
|
Glaxo Wellcome
|
|
Protocol FAP30007, Asthma
|
10/00
|
|
Protocol FAP30008, Asthma
|
10/00
|
|
|
Searle Pharmaceutical
|
|
Protocol N49-96-02-024, Osteoarthritis/Rheumatoid Arthritis
|
09/97 – 11/99
|
|
Protocol N49-97-02-071, Gastrointestinal/Osteoarthritis/Rheumatoid Arthritis
|
07/97 – 12/97
|
|
Protocol N49-98-02-102, Gastrointestinal/Osteoarthritis/Rheumatoid Arthritis
|
10/98 – 10/99
|
|
Protocol N49-98-02-118, Osteoarthritis of Knee
|
06/99 – 11/99
|
|
Protocol N49-00-02-149, Hypertension with Osteoarthritis
|
12/99 – 03/01
|
|
Protocol N49-98-02-047, Hypertension with Osteoarthritis
|
12/00 – 03/01
|
|
Protocol N49-98-02-047, Hypertension with Osteoarthritis
|
12/00 – 03/01
|
|
|
Fujisawa Pharmaceutical
|
|
Protocol 98-0-049, Rheumatoid Arthritis
|
05/00 – 01/01
|
|
Protocol 98-0-051, Rheumatoid Arthritis
|
09/00 – 01/01
|
|
|
ViroPharma
|
|
Protocol 843-020, Viral Syndrome
|
09/00 – 01/01
|
|
|
Bristol-Myers Squibb
|
|
Protocol CV 137-120, Hypertension
|
|
|
|
RW Johnson Pharmaceuticals
|
|
Protocol 57504-RA-001, Rheumatoid Arthritis
|
09/98 – 03/99
|
|
|
Eli Lilly and Company
|
|
Protocol H5P-M-BWWC/a, Rheumatoid Arthritis
|
10/98 – 08/99
|
|
|
Ortho-McNeil Pharmaceutical
|
|
Protocol CAPSS 105, Osteoarthritis
|
12/99 – 09/00
|
|
Protocol CAPSS 112, Chronic Low Back Pain
|
03/00 – 03/01
|
|
Protocol CAPSS 114, Osteoarthritis
|
03/00 – 03/01
|
|
|
McNeil Consumer Healthcare
|
|
Protocol 98-055, Osteoarthritis
|
08/00
|
|
|
Bayer Pharmaceuticals
|
|
Protocol 100160, Chronic Bronchitis
|
09/98 – 05/99
|
|
|
Purdue
|
|
Protocol BP99-0203, Osteoarthritis
|
07/99 – 09/99
|
|
Protocol BP98-1201, Chronic Low Back Pain
|
03/99 – 12/99
|
Protocol BUP-3019, Osteoarthritis |
04/05 – 06/05 |
|
|
Schering-Plough
|
|
Protocol C98-189, Rheumatoid Arthritis
|
03/99 – 04/00
|
|
|
Astra Merck
|
|
Protocol 205, Hypertension
|
06/98 – 02/99
|
|
|
Merck
|
|
Protocol 102-00, Osteoarthritis
|
03/99 – 03/00
|
|
Protocol 164-00, Osteoporosis
|
08/00 – 03/01
|
|
Protocol 24, Rheumatoid Arthritis
|
05/00
|
|
Protocol 25, Rheumatoid Arthritis
|
04/00
|
|
Protocol 049-00, Gout
|
02/01
|
|
Protocol 189-00, Osteoporosis
|
05/01
|
|
|
Neoral
|
|
Protocol OLR-351, Rheumatoid Arthritis
|
11/96 – 10/97
|
|
|
Ovaries Pharmaceuticals
|
|
Protocol CCOX189-110, Rheumatoid Arthritis/Gastrointestinal
|
05/01
|
|
|
Pfizer
|
|
Protocol A0661036, Acute Bacterial Sinusitis
|
12/00
|
|
|
Roberts Labs
|
|
Protocol 22163-302R1, Osteoarthritis
|
11/00
|
|
|
ILEX Oncology
|
|
Protocol OXPL213, Hyperuricemia
|
02/00
|
|
|
Endo Pharmaceuticals
|
|
Protocol EN3202.016, Chronic Low Back Pain
|
06/01
|
|
Protocol EN3202.021, Chronic Low Back Pain
|
07/01
|
|
|
Amgen
|
|
Protocol IL1ra 20000223, Rheumatoid Arthritis
|
03/01
|
|
Protocol 990145, Rheumatoid Arthritis
|
11/99
|
|
Protocol 990757, Rheumatoid Arthritis
|
10/99
|
|
Protocol Radius 2, Rheumatoid Arthritis
|
Ongoing
|
|
Protocol 20010108, Rheumatoid Arthritis
|
8/03
|
|
Protocol 20020103, Rheumatoid Arthritis
|
10/03
|
|
|
Alexion Pharmaceuticals
|
|
Protocol C01-004, Rheumatoid Arthritis
|
8/02
|
|
Protocol E01-004, Rheumatoid Arthritis
|
08/03 – 08/04
|
|